2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine
- PMID: 20079393
- PMCID: PMC2842477
- DOI: 10.1016/j.humimm.2010.01.004
2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine
Abstract
Interferon-induced antiviral genes are crucial players in innate antiviral defense and potential determinants of immune response heterogeneity. We selected 114 candidate single-nucleotide polymorphisms (SNPs) from 12 antiviral genes using an LD tagSNP selection approach and genotyped them in a cohort of 738 school children immunized with two doses of rubella vaccine. Associations between SNPs/haplotypes and rubella virus-specific immune measures were assessed using linear regression methodologies. We identified 23 significant associations (p < 0.05) between polymorphisms within the 2'-5'-oligoadenylate synthetase (OAS) gene cluster, and rubella virus-specific IL-2, IL-10, IL-6 secretion, and antibody levels. The minor allele variants of three OAS1 SNPs (rs3741981/Ser162Gly, rs1051042/Thr361Arg, rs2660), located in a linkage disequilibrium block of functional importance, were significantly associated with an increase in rubella virus-specific IL-2/T(h)1 response (p <or = 0.024). Seven OAS1 and OAS3 promoter/regulatory SNPs were similarly associated with IL-2 secretion. Importantly, two SNPs (rs3741981 and rs10774670) independently cross-regulated rubella virus-specific IL-10 secretion levels (p < or = 0.031). Furthermore, both global tests and individual haplotype analyses revealed significant associations between OAS1 haplotypes and rubella virus-specific cytokine secretion. Our results suggest that innate immunity and OAS genetic variations are likely involved in modulating the magnitude and quality of the adaptive immune responses to live attenuated rubella vaccine.
Figures
Similar articles
-
Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.Vaccine. 2011 Nov 8;29(48):8988-97. doi: 10.1016/j.vaccine.2011.09.043. Epub 2011 Sep 20. Vaccine. 2011. PMID: 21939710 Free PMC article.
-
SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine.Immunogenetics. 2010 Apr;62(4):197-210. doi: 10.1007/s00251-010-0423-6. Epub 2010 Mar 10. Immunogenetics. 2010. PMID: 20217072 Free PMC article.
-
Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines.Immunogenetics. 2014 Nov;66(11):663-9. doi: 10.1007/s00251-014-0796-z. Epub 2014 Aug 21. Immunogenetics. 2014. PMID: 25139337 Free PMC article.
-
Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children.Immunogenetics. 2015 Oct;67(10):547-61. doi: 10.1007/s00251-015-0864-z. Epub 2015 Sep 2. Immunogenetics. 2015. PMID: 26329766 Free PMC article.
-
Evaluate the relationship between polymorphisms of OAS1 gene and susceptibility to chronic hepatitis C with high resolution melting analysis.Clin Exp Med. 2013 Aug;13(3):171-6. doi: 10.1007/s10238-012-0193-6. Epub 2012 Jun 19. Clin Exp Med. 2013. PMID: 22710942 Free PMC article.
Cited by
-
Genetic Variants within SARS-CoV-2 Human Receptor Genes May Contribute to Variable Disease Outcomes in Different Ethnicities.Int J Mol Sci. 2023 May 13;24(10):8711. doi: 10.3390/ijms24108711. Int J Mol Sci. 2023. PMID: 37240057 Free PMC article. Review.
-
Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients.Front Immunol. 2023 May 5;14:1172993. doi: 10.3389/fimmu.2023.1172993. eCollection 2023. Front Immunol. 2023. PMID: 37215103 Free PMC article. Review.
-
SARS-CoV-2 infection in children: A 24 months experience with focus on risk factors in a pediatric tertiary care hospital in Milan, Italy.Front Pediatr. 2023 Feb 17;11:1082083. doi: 10.3389/fped.2023.1082083. eCollection 2023. Front Pediatr. 2023. PMID: 36873632 Free PMC article.
-
Vaccinomics: A scoping review.Vaccine. 2023 Mar 31;41(14):2357-2367. doi: 10.1016/j.vaccine.2023.02.009. Epub 2023 Feb 18. Vaccine. 2023. PMID: 36803903 Free PMC article. Review.
-
Current Challenges in Vaccinology.Front Immunol. 2020 Jun 25;11:1181. doi: 10.3389/fimmu.2020.01181. eCollection 2020. Front Immunol. 2020. PMID: 32670279 Free PMC article. Review.
References
-
- Dean M., Carrington M., O'Brien S.J. Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet. 2002;3:263–292. - PubMed
-
- Hill A.V. The genomics and genetics of human infectious disease susceptibility. Annu Rev Genomics Hum Genet. 2001;2:373–400. - PubMed
-
- Hill A.V. Aspects of genetic susceptibility to human infectious diseases. Annu Rev Genet. 2006;40:469–486. - PubMed
-
- Poland G.A., Ovsyannikova I.G., Jacobson R.M., Smith D.I. Heterogeneity in vaccine immune response: The role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther. 2007;82:653–664. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials